During cell therapy development, some scientists are moving away from viral transfection and toward electroporation for introducing CRISPR systems and other nucleic acid payloads. As electroporation systems for both large- and small-scale cell production continue to improve, this method serves as a quicker, simpler, and safer alternative to viral transfection.

Download this article from Thermo Fisher Scientific to learn how scientists employ electroporation in place of viral delivery for cell therapy applications and beyond.

Sponsored by